Invention Grant
- Patent Title: Imidazo-, pyrazolopyrazines and imidazotriazines and their use
- Patent Title (中): 咪唑并，吡唑并吡嗪和咪唑并嗪及其用途
-
Application No.: US12668633Application Date: 2008-06-28
-
Publication No.: US08476267B2Publication Date: 2013-07-02
- Inventor: Stephan Siegel , Andreas Wilmen , Susanne Röhrig , Niels Svenstrup , Mark Jean Gnoth , Stefan Heitmeier , Ulrich Rester , Adrian Tersteegen , Michael Gerisch
- Applicant: Stephan Siegel , Andreas Wilmen , Susanne Röhrig , Niels Svenstrup , Mark Jean Gnoth , Stefan Heitmeier , Ulrich Rester , Adrian Tersteegen , Michael Gerisch
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: DE102007032349 20070711
- International Application: PCT/EP2008/005305 WO 20080628
- International Announcement: WO2009/007029 WO 20090115
- Main IPC: A61K31/535
- IPC: A61K31/535
Abstract:
The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological disorders, preferably of leukopenias and neutropenias.
Public/Granted literature
- US20110053929A1 IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE Public/Granted day:2011-03-03
Information query
